Physician profile
Arun Thomas
NPI 1750941886
$1,944.39
in general payments reported to CMS, 2019-2025
16 companies · $830 in 2025
The $830 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.59 · 2022: $13.93 · 2023: $401 · 2024: $685 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,915.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $613.77 | 2022-2025 | Vraylar, Ubrelvy, Synthroid |
| Lilly USA, LLC | $213.64 | 2023-2025 | Zepbound, Mounjaro |
| Corcept Therapeutics | $183.68 | 2025 | Korlym |
| Novo Nordisk INC | $163.55 | 2024-2025 | Wegovy, Ozempic |
| Bausch Health US, LLC | $147.97 | 2023-2024 | Wellbutrin, Aplenzin |
| Pfizer INC. | $111.72 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $111.15 | 2023-2025 | Breztri, Airsupra |
| Exact Sciences Corporation | $101.16 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $86.21 | 2024 | Veozah |
| Dexcom, INC. | $60.20 | 2025 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $56.05 | 2024 | Quviviq |
| Dynavax Technologies Corporation | $21.14 | 2024 | Heplisav-B |
| Ptc Therapeutics, INC. | $20.74 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.79 | 2023 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $19.03 | 2023 | Pediarix, Bexsero, Shingrix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.